Table 1.
Patients characteristics per hospital outcome
| Variable | Hospital decedents (n = 639) |
Hospital survivors (n = 414) |
P value |
|---|---|---|---|
| Male gender | 404 (63.2%) | 287 (69.3%) | 0.05 |
| Age (years) | 63 [55–71] | 63 [53–71] | 0.29 |
| Type of malignancy | |||
| Lung | 157 (24.6%) | 45 (10.9%) | < 0.001 |
| Colorectal | 90 (14.1%) | 88 (21.3%) | |
| Breast | 68 (10.6%) | 61 (14.7%) | |
| Head and neck | 79 (12.4%) | 46 (11.1%) | |
| Others | 245 (38.4%) | 174 (42.0%) | |
| Diagnosis to ICU (months) | 3 [1–14] | 6 [1–36] | |
| Cancer status | 0.002 | ||
| Complete remission | 99 (15.5%) | 90 (21.8%) | – |
| Partial remission | 92 (14.4%) | 51 (12.4%) | 0.004 |
| Diagnosis during ICU stay | 52 (13.0%) | 19 (7.5%) | 0.04 |
| Distant metastases | 384 (60.1%) | 177 (42.8%) | < 0.001 |
| Severity at ICU admission | |||
| SAPS II | 54 [42–72] | 39 [30–50] | < 0.001 |
| SOFA | 8 [5–12] | 4 [2–7] | < 0.001 |
| Treatments during ICU stay | |||
| Invasive mechanical ventilation | 518 (81.3%) | 203 (49.0%) | < 0.001 |
| Vasopressors and/or inotropic drug | 403 (63.1%) | 126 (30.5%) | < 0.001 |
| Renal replacement therapy | 127 (19.9%) | 41 (10.0%) | < 0.001 |
| Cancer chemotherapy | 27 (4.4%) | 13 (3.3%) | 0.48 |
| Neutropenia during ICU stay | 52 (8.2%) | 18 (4.4%) | 0.02 |